GELS Stock Analysis: Buy, Sell, or Hold?

GELS - Gelteq Limited Ordinary Shares

Pharmaceutical Preparations
$0.97
-0.04 (-3.95%) ▼
HOLD
LOW Confidence
Protect Your GELS Gains
Last Updated: January 30, 2026

Get Alerted When GELS Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
📊 HOLD: GELS shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.

In-depth Analysis How we analyze

Valuation Analysis: GELS is currently trading at $0.97, which is considered fair relative to its 30-day fair value range of $0.81 to $1.08.

Technical Outlook: Technically, GELS is in a strong downtrend. The price is currently testing key support at $0.97. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.0% recently.

Market Sentiment: GELS has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position FAIR
Fair Price Range $0.81 - $1.08
Company Quality Score 55/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 79.4%

Protect Your Profits

Holding GELS? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

  • NEUTRAL: Price in fair range
  • BULLISH: Strong technical setup (60/100)
  • BULLISH: High volume confirmation
  • BEARISH: Downward momentum (-4.0%)
  • CAUTION: Recommendation downgraded due to -7.6% 5-day decline

Fair Price Analysis

30-Day Fair Range $0.81 - $1.08
Current vs Fair Value FAIR

Support & Resistance Levels

Support Level $0.97
Resistance Level $1.31
Current Trend Strong Downtrend

Fundamental Context

Revenue Growth (YoY) 59.4%
Last updated: February 01, 2026 4:13 AM ET
Data refreshes hourly during market hours. Next update: 5:13 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %

Top Rated Drug Manufacturers - Specialty & Generic Stocks

Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
NBIX
Neurocrine Biosciences I…
STRONG BUY
25 analysts
$179 62 BUY
ZTS
Zoetis Inc
STRONG BUY
19 analysts
$158 56 HOLD
LNTH
Lantheus Holdings Inc
STRONG BUY
13 analysts
$84 57 HOLD
BCRX
BioCryst Pharmaceuticals…
STRONG BUY
12 analysts
$21 55 HOLD
HCM
HUTCHMED DRC
STRONG BUY
14 analysts
$21 57 HOLD

Advanced GELS Option Strategies

Professional options setups generated by AI based on today's GELS price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for GELS

GELS Technical Chart GELS Price Prediction GELS Investment Advisor GELS Fair Price Analyzer GELS Options Advisor GELS Options Chain GELS Options Analysis GELS Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals